View in EDS HTML Full Text PDF Full Text

Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change Thresholds.

Saved in:
Bibliographic Details
Title: Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change Thresholds.
Authors: Nelson, Meredith A. (AUTHOR), Schmitt, Lauren M. (AUTHOR), Horn, Paul S. (AUTHOR), Berry-Kravis, Elizabeth (AUTHOR), Hessl, David (AUTHOR), Shaffer, Rebecca C. (AUTHOR), Carpenter, Randall (AUTHOR), Budimirovic, Dejan B. (AUTHOR), Wang, Paul (AUTHOR), Reisinger, Debra L. (AUTHOR), Walton-Bowen, Karen (AUTHOR), Erickson, Craig A. (AUTHOR)
Source: Journal of Autism & Developmental Disorders. Apr2026, Vol. 56 Issue 4, p1658-1670. 13p.
Subjects: Baclofen, Children with disabilities, Questionnaires, Visual analog scale, Fragile X syndrome, Parent attitudes, Descriptive statistics, Parenting, Anxiety, Psychological stress, Parents of children with disabilities, Health outcome assessment, Comparative studies, Data analysis software, Psychosocial factors, Mental depression
Abstract: Estimating meaningful change thresholds (MCT) on clinical outcome assessments is an important consideration when evaluating treatments. In fragile X syndrome (FXS) research, there has been no consensus on how to define MCT's on several commonly used outcome measures. The purpose of the current study was to determine clinically relevant MCT's of caregiver-rated assessments using data from a phase 3 clinical trials of arbaclofen (Berry-Kravis et al., 2017). Data were collected as a part of previous phase 3, double-blind, placebo-controlled studies of arbaclofen in individuals with FXS (Berry-Kravis et al., 2017). The two studies enrolled age groups of 5–11-years (n = 159) and 12–50-years (n = 119). The current study examines meaningful within-patient change thresholds from baseline to treatment week 8 across several measures: ABC-CFXS; PSI; Vineland-II; and a Visual Analog Scale (VAS) of Anxiety and Disruptive Behaviors. MCT's were established by using anchor-based methods, using the CGI-S and CGI-I as anchors. Examining the results of the anchor-based analyses and visual CDF plots, MCT's were observed for the pediatric study for the ABC-CFXS subscales (with a range depending on use of CGI-S or CGI-I as anchor): Irritability: 11.1–14.8 points; Hyperactivity: 6.7–8.9 points; and Socially Unresponsive/Lethargic: 6.6–8.1 points; as well both VAS subscales: Anxiety: 28.3–36.2 mm; and Disruptive Behavior: 22.4–27.4 mm. Such thresholds were not observed for the Vineland-II and PSI subscales. Our analysis of MCT's helps set the stage for interpreting clinical trial results in FXS. This may include use of relevant subscales of the ABC-CFXS and VAS as primary outcomes using the MCT's for response definition. This work may help define future study inclusion criteria and enable future interpretation of treatment outcome results in the field. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Autism & Developmental Disorders is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 192345534
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change Thresholds.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Nelson%2C+Meredith+A%2E%22">Nelson, Meredith A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmitt%2C+Lauren+M%2E%22">Schmitt, Lauren M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Horn%2C+Paul+S%2E%22">Horn, Paul S.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berry-Kravis%2C+Elizabeth%22">Berry-Kravis, Elizabeth</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hessl%2C+David%22">Hessl, David</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shaffer%2C+Rebecca+C%2E%22">Shaffer, Rebecca C.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carpenter%2C+Randall%22">Carpenter, Randall</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Budimirovic%2C+Dejan+B%2E%22">Budimirovic, Dejan B.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Paul%22">Wang, Paul</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reisinger%2C+Debra+L%2E%22">Reisinger, Debra L.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Walton-Bowen%2C+Karen%22">Walton-Bowen, Karen</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Erickson%2C+Craig+A%2E%22">Erickson, Craig A.</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Journal+of+Autism+%26+Developmental+Disorders%22">Journal of Autism & Developmental Disorders</searchLink>. Apr2026, Vol. 56 Issue 4, p1658-1670. 13p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Baclofen%22">Baclofen</searchLink><br /><searchLink fieldCode="DE" term="%22Children+with+disabilities%22">Children with disabilities</searchLink><br /><searchLink fieldCode="DE" term="%22Questionnaires%22">Questionnaires</searchLink><br /><searchLink fieldCode="DE" term="%22Visual+analog+scale%22">Visual analog scale</searchLink><br /><searchLink fieldCode="DE" term="%22Fragile+X+syndrome%22">Fragile X syndrome</searchLink><br /><searchLink fieldCode="DE" term="%22Parent+attitudes%22">Parent attitudes</searchLink><br /><searchLink fieldCode="DE" term="%22Descriptive+statistics%22">Descriptive statistics</searchLink><br /><searchLink fieldCode="DE" term="%22Parenting%22">Parenting</searchLink><br /><searchLink fieldCode="DE" term="%22Anxiety%22">Anxiety</searchLink><br /><searchLink fieldCode="DE" term="%22Psychological+stress%22">Psychological stress</searchLink><br /><searchLink fieldCode="DE" term="%22Parents+of+children+with+disabilities%22">Parents of children with disabilities</searchLink><br /><searchLink fieldCode="DE" term="%22Health+outcome+assessment%22">Health outcome assessment</searchLink><br /><searchLink fieldCode="DE" term="%22Comparative+studies%22">Comparative studies</searchLink><br /><searchLink fieldCode="DE" term="%22Data+analysis+software%22">Data analysis software</searchLink><br /><searchLink fieldCode="DE" term="%22Psychosocial+factors%22">Psychosocial factors</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+depression%22">Mental depression</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Estimating meaningful change thresholds (MCT) on clinical outcome assessments is an important consideration when evaluating treatments. In fragile X syndrome (FXS) research, there has been no consensus on how to define MCT's on several commonly used outcome measures. The purpose of the current study was to determine clinically relevant MCT's of caregiver-rated assessments using data from a phase 3 clinical trials of arbaclofen (Berry-Kravis et al., 2017). Data were collected as a part of previous phase 3, double-blind, placebo-controlled studies of arbaclofen in individuals with FXS (Berry-Kravis et al., 2017). The two studies enrolled age groups of 5–11-years (n = 159) and 12–50-years (n = 119). The current study examines meaningful within-patient change thresholds from baseline to treatment week 8 across several measures: ABC-CFXS; PSI; Vineland-II; and a Visual Analog Scale (VAS) of Anxiety and Disruptive Behaviors. MCT's were established by using anchor-based methods, using the CGI-S and CGI-I as anchors. Examining the results of the anchor-based analyses and visual CDF plots, MCT's were observed for the pediatric study for the ABC-CFXS subscales (with a range depending on use of CGI-S or CGI-I as anchor): Irritability: 11.1–14.8 points; Hyperactivity: 6.7–8.9 points; and Socially Unresponsive/Lethargic: 6.6–8.1 points; as well both VAS subscales: Anxiety: 28.3–36.2 mm; and Disruptive Behavior: 22.4–27.4 mm. Such thresholds were not observed for the Vineland-II and PSI subscales. Our analysis of MCT's helps set the stage for interpreting clinical trial results in FXS. This may include use of relevant subscales of the ABC-CFXS and VAS as primary outcomes using the MCT's for response definition. This work may help define future study inclusion criteria and enable future interpretation of treatment outcome results in the field. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Journal of Autism & Developmental Disorders is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=192345534
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10803-024-06634-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 1658
    Subjects:
      – SubjectFull: Baclofen
        Type: general
      – SubjectFull: Children with disabilities
        Type: general
      – SubjectFull: Questionnaires
        Type: general
      – SubjectFull: Visual analog scale
        Type: general
      – SubjectFull: Fragile X syndrome
        Type: general
      – SubjectFull: Parent attitudes
        Type: general
      – SubjectFull: Descriptive statistics
        Type: general
      – SubjectFull: Parenting
        Type: general
      – SubjectFull: Anxiety
        Type: general
      – SubjectFull: Psychological stress
        Type: general
      – SubjectFull: Parents of children with disabilities
        Type: general
      – SubjectFull: Health outcome assessment
        Type: general
      – SubjectFull: Comparative studies
        Type: general
      – SubjectFull: Data analysis software
        Type: general
      – SubjectFull: Psychosocial factors
        Type: general
      – SubjectFull: Mental depression
        Type: general
    Titles:
      – TitleFull: Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change Thresholds.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nelson, Meredith A.
      – PersonEntity:
          Name:
            NameFull: Schmitt, Lauren M.
      – PersonEntity:
          Name:
            NameFull: Horn, Paul S.
      – PersonEntity:
          Name:
            NameFull: Berry-Kravis, Elizabeth
      – PersonEntity:
          Name:
            NameFull: Hessl, David
      – PersonEntity:
          Name:
            NameFull: Shaffer, Rebecca C.
      – PersonEntity:
          Name:
            NameFull: Carpenter, Randall
      – PersonEntity:
          Name:
            NameFull: Budimirovic, Dejan B.
      – PersonEntity:
          Name:
            NameFull: Wang, Paul
      – PersonEntity:
          Name:
            NameFull: Reisinger, Debra L.
      – PersonEntity:
          Name:
            NameFull: Walton-Bowen, Karen
      – PersonEntity:
          Name:
            NameFull: Erickson, Craig A.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: Apr2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 01623257
          Numbering:
            – Type: volume
              Value: 56
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Journal of Autism & Developmental Disorders
              Type: main
ResultId 1